CIK 0001759186 · Non-accelerated filer<br>Smaller reporting company
Z Squared Inc.
Sign in to watch- Ticker
- ZSQR
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 981465952
- Phone
- 954-400-9994
- Business address
- 550 SOUTH ANDREWS AVE., STE #700, FORT LAUDERDALE, FL, 33301
- Former names
- Coeptis Therapeutics Holdings, Inc., Bull Horn Holdings Corp.
- Open-market buys, last 90 days
- $7,840
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$7,840. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Yerace Daniel Alexander VP Operations | Option exercise | +10,000 | $10.41 | $104K | 70,531 |
| 2026-02-11 | Yerace Daniel Alexander VP Operations | Grant or award | +20,000 | 70,531 | ||
| 2026-02-11 | DeSilva Tara Director | Option exercise | +5,700 | $10.56 | $60K | 8,950 |
| 2026-02-11 | DeSilva Tara Director | Grant or award | +3,250 | 8,950 | ||
| 2026-02-11 | Cochran Christopher P. Director | Option exercise | +5,700 | $10.56 | $60K | 8,950 |
| 2026-02-11 | Cochran Christopher P. Director | Grant or award | +3,250 | 8,950 | ||
| 2026-02-11 | Salkind Gene Director | Option exercise | +5,700 | $10.56 | $60K | 13,161 |
| 2026-02-11 | Salkind Gene Director | Grant or award | +3,250 | 13,161 | ||
| 2026-02-11 | Sheehy Christine Elise VP Compliance and Secy | Option exercise | +1,000 | $10.56 | $11K | 64,031 |
| 2026-02-11 | Sheehy Christine Elise VP Compliance and Secy | Grant or award | +12,500 | 64,031 | ||
| 2025-03-04 | Deschamps Philippe Director | Grant or award · Non-qualified Stock Options (right to buy) | +5,700 | 8,950 | ||
| 2025-03-04 | Cogley Brian Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to buy) | +10,000 | 22,500 | ||
| 2025-03-04 | Yerace Daniel Alexander VP of Operations | Grant or award · Non-Qualified Stock Options (right to buy) | +5,000 | 25,000 | ||
| 2025-03-04 | Sheehy Christine Elise VP Compliance and Secy | Grant or award · Non-Qualified Stock Options (right to buy) | +1,000 | 13,500 | ||
| 2025-03-04 | Salkind Gene Director | Grant or award · Non-qualified Stock Options (right to buy) | +5,700 | 8,950 | ||
| 2025-03-04 | Mehalick David CEO and President | Grant or award · Non-Qualified Stock Options (right to buy) | +28,875 | 200,125 | ||
| 2025-03-04 | DeSilva Tara Director | Grant or award · Non-qualified Stock Options (right to buy) | +5,700 | 8,950 | ||
| 2025-03-04 | Cochran Christopher P. Director | Grant or award · Non-qualified Stock Options (right to buy) | +5,700 | 8,950 | ||
| 2025-03-04 | Calise Chris Director | Grant or award · Non-qualified Stock Options (right to buy) | +5,700 | 8,950 | ||
| 2024-01-12 | DeSilva Tara Director | Purchase | +466 | $0.56 | $261 | 30,466 |
Page 5 of 7 · 129 trades